SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-178428
Filing Date
2018-05-30
Accepted
2018-05-30 16:05:27
Documents
39
Period of Report
2018-05-30

Document Format Files

Seq Description Document Type Size
1 6-K d554526d6k.htm 6-K 13688
2 EX-99.1 d554526dex991.htm EX-99.1 159481
3 EX-99.2 d554526dex992.htm EX-99.2 69025
4 EX-99.3 d554526dex993.htm EX-99.3 58983
11 GRAPHIC g554526g0530065821479.jpg GRAPHIC 3295
  Complete submission text file 0001193125-18-178428.txt   1402661

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT asnd-20180331.xml EX-101.INS 170121
6 XBRL TAXONOMY EXTENSION SCHEMA asnd-20180331.xsd EX-101.SCH 20872
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asnd-20180331_cal.xml EX-101.CAL 35161
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asnd-20180331_def.xml EX-101.DEF 52219
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE asnd-20180331_lab.xml EX-101.LAB 157604
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asnd-20180331_pre.xml EX-101.PRE 114421
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 18868118
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1